Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 3, 2021
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
[ Wed, Nov 03rd 2021
] - WOPRAI
Geulah Livshits Maintained (VYGR) at Hold with Decreased Target to $4 on, Nov 3rd, 2021
Geulah Livshits of Chardan Capital, Maintained "Voyager Therapeutics, Inc." (VYGR) at Hold with Decreased Target from $5.5 to $4 on, Nov 3rd, 2021.
Geulah has made no other calls on VYGR in the last 4 months.
There is 1 other peer that has a rating on VYGR. Out of the 1 peers that are also analyzing VYGR, 0 agree with Geulah's Rating of Hold.
This is the rating of the analyst that currently disagrees with Geulah
- Jack Allen of "Baird" Upgraded from Hold to Buy and Increased Target to $9 on, Thursday, October 7th, 2021
